Showing 1 - 6 of 6
We consider a dose-finding trial in phase IIB of drug development. For choosing an appropriate design for this trial the specification of two points is critical: an appropriate model for describing the dose-effect relationship and the specification of the aims of the trial (objectives), which...
Persistent link: https://www.econbiz.de/10010298204
We consider a dose-finding trial in phase IIB of drug development. For choosing an appropriate design for this trial the specification of two points is critical: an appropriate model for describing the dose-effect relationship and the specification of the aims of the trial (objectives), which...
Persistent link: https://www.econbiz.de/10003581859
Persistent link: https://www.econbiz.de/10001602614
Persistent link: https://www.econbiz.de/10001639395
Persistent link: https://www.econbiz.de/10001586508
We consider a dose-finding trial in phase IIB of drug development. For choosing an appropriate design for this trial the specification of two points is critical: an appropriate model for describing the dose-effect relationship and the specification of the aims of the trial (objectives), which...
Persistent link: https://www.econbiz.de/10009216966